Terug
Dagbereik
€ 84,71
€ 88,32
52-Weeksbereik
€ 36,36
€ 120,74
Volume
1.506.773
50D / 200D Gem.
€ 101,84
/
€ 78,08
Vorige Slotkoers
€ 85,18
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -26,8 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,8 |
| Net Margin % | -42,4 | 3,9 |
| Rev Growth 5Y % | 27,3 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 130,27
+53.3%
Low: € 75,00
High: € 175,00
Forward WPA
-€ 2,95
Omzet Sch.
1,3 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,69
€ 1,65 – € 1,81
|
3,1 B | 3 |
| FY2029 |
€ 0,50
€ 0,49 – € 0,54
|
2,5 B | 3 |
| FY2028 |
-€ 0,21
-€ 0,69 – € 0,57
|
2,1 B | 9 |
Belangrijkste Punten
Revenue grew 27,32% annually over 5 years — strong growth
Negative free cash flow of -233,07M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,56%
Capital efficient — spends only 4,92% of revenue on capex
Groei
Revenue Growth (5Y)
27,32%
Revenue (1Y)32,88%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-20,67%
Net Margin-42,39%
Op. Margin-44,43%
Veiligheid
Debt / Equity
N/A
Current Ratio4,84
Interest Coverage-111,96
Waardering
P/E Ratio
-26,77
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 32,88% | Revenue Growth (3Y) | 31,96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 27,32% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 982,02M | Net Income (TTM) | -416,28M |
| ROE | N/A | ROA | -20,67% |
| Gross Margin | 64,46% | Operating Margin | -44,43% |
| Net Margin | -42,39% | Free Cash Flow (TTM) | -233,07M |
| ROIC | -20,67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4,84 |
| Interest Coverage | -111,96 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -26,77 | P/B Ratio | N/A |
| P/S Ratio | 11,35 | PEG Ratio | 4,56 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 11,14B | Enterprise Value | 12,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 982,02M | 739,02M | 563,95M | 449,54M | 373,65M |
| Net Income | -416,28M | -436,37M | -479,45M | -654,59M | -405,67M |
| EPS (Diluted) | -3,32 | -3,56 | -4,28 | -6,41 | -3,80 |
| Gross Profit | 633,01M | 449,22M | 336,90M | 293,21M | 250,74M |
| Operating Income | -436,30M | -443,59M | -564,73M | -544,38M | -411,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,01B | 1,49B | 1,79B | 1,61B | 2,20B |
| Total Liabilities | 2,11B | 1,63B | 1,63B | 1,55B | 1,56B |
| Shareholders' Equity | -99,31M | -139,65M | 158,68M | 60,18M | 645,01M |
| Total Debt | 1,68B | 1,34B | 1,35B | 1,37B | 1,37B |
| Cash & Equivalents | 378,20M | 525,54M | 1,13B | 141,65M | 492,20M |
| Current Assets | 1,47B | 1,06B | 1,35B | 1,19B | 1,11B |
| Current Liabilities | 302,73M | 225,58M | 205,92M | 193,22M | 194,69M |